These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 24635658)
1. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658 [TBL] [Abstract][Full Text] [Related]
2. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Caescu CI; Jeschke GR; Turk BE Biochem J; 2009 Oct; 424(1):79-88. PubMed ID: 19715556 [TBL] [Abstract][Full Text] [Related]
3. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein. McDonald AJ; Dibble JP; Evans EG; Millhauser GL J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244 [TBL] [Abstract][Full Text] [Related]
4. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Pruessmeyer J; Ludwig A Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988 [TBL] [Abstract][Full Text] [Related]
5. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase. Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060 [TBL] [Abstract][Full Text] [Related]
6. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms. Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658 [TBL] [Abstract][Full Text] [Related]
7. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis. Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057 [TBL] [Abstract][Full Text] [Related]
9. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates. Minond D; Cudic M; Bionda N; Giulianotti M; Maida L; Houghten RA; Fields GB J Biol Chem; 2012 Oct; 287(43):36473-87. PubMed ID: 22927435 [TBL] [Abstract][Full Text] [Related]
11. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Bozkulak EC; Weinmaster G Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010 [TBL] [Abstract][Full Text] [Related]
12. Expression profile of ADAM10 and ADAM17 in allergic rhinitis. Chueh HW; Park SK; Hur DY; Bae WY Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527 [TBL] [Abstract][Full Text] [Related]
13. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells. Ebsen H; Schröder A; Kabelitz D; Janssen O PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797 [TBL] [Abstract][Full Text] [Related]
14. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483 [TBL] [Abstract][Full Text] [Related]
15. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. Gardiner EE; Karunakaran D; Shen Y; Arthur JF; Andrews RK; Berndt MC J Thromb Haemost; 2007 Jul; 5(7):1530-7. PubMed ID: 17445093 [TBL] [Abstract][Full Text] [Related]
16. Degradome of soluble ADAM10 and ADAM17 metalloproteases. Scharfenberg F; Helbig A; Sammel M; Benzel J; Schlomann U; Peters F; Wichert R; Bettendorff M; Schmidt-Arras D; Rose-John S; Moali C; Lichtenthaler SF; Pietrzik CU; Bartsch JW; Tholey A; Becker-Pauly C Cell Mol Life Sci; 2020 Jan; 77(2):331-350. PubMed ID: 31209506 [TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Ludwig A; Hundhausen C; Lambert MH; Broadway N; Andrews RC; Bickett DM; Leesnitzer MA; Becherer JD Comb Chem High Throughput Screen; 2005 Mar; 8(2):161-71. PubMed ID: 15777180 [TBL] [Abstract][Full Text] [Related]
18. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling. Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454 [TBL] [Abstract][Full Text] [Related]
19. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880 [TBL] [Abstract][Full Text] [Related]
20. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17. Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]